Study Group Alegent Creighton Health Heart & Vascular Specialists (Ref number:169)
Description EXERRT
Study Number EXERRT
Disease Site Heart
Condition Cardiac
Phone Number 402-593-3686
Contact Name Barb Lapke
Additional Information A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone For Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)